Objective: To examine the association between enlarged perivascular spaces (EPVS) and the prevalence and extent of small acute diffusion-weighted imaging (DWI) lesions (SA-DWIL) in patients with spontaneous supratentorial intracerebral hemorrhage (ICH).
Virchow-Robin perivascular spaces are extensions of the subarachnoid space that accompany penetrating vessels entering the brain parenchyma, and serve as draining channels for the brain. Enlarged perivascular spaces (EPVS) can be visualized on MRI, and are commonly seen in the centrum semiovale (CSO-EPVS) in CAA-related ICH, and basal ganglia (BG-EPVS) in hypertensive ICH. 11, 12 Blood can extend to the perivascular spaces and subarachnoid space. 13, 14 Therefore, we hypothesized that EPVS are involved in the pathogenesis of ICH-associated SA-DWIL. We postulated that EPVS facilitate transport of blood toxic products to areas distant from the hemorrhage through the subarachnoid space, and that ICH patients with high EPVS would have more SA-DWIL. We examined the association between EPVS and the prevalence and extent of SA-DWIL in ICH patients in this study.
METHODS Study population and data collection. We conducted a retrospective review of a consecutive cohort of ICH patients who were admitted to the Stroke Service at Beth Israel Deaconess Medical Center from October 2007 through August 2014. Patients were included in this study if they had spontaneous supratentorial ICH and MRI with diffusionweighted imaging (DWI) scan performed within 1 month of ICH onset. Patients who did not have MRI DWI within 1 month of ICH onset, and those with (1) secondary causes of ICH such as underlying aneurysm, vascular malformation, head trauma, venous infarction, hemorrhagic transformation of ischemic infarction, or tumor; (2) isolated intraventricular hemorrhage (IVH); or (3) infratentorial ICH were excluded.
We retrieved baseline clinical and demographic information, including age; sex; ICH onset to MRI scan time; comorbid conditions, including history of hypertension, atrial fibrillation, diabetes mellitus, coronary artery disease, cognitive impairment, hyperlipidemia, prior ICHs, or prior ischemic stroke/TIA; medications used before ICH onset, such as antiplatelet agents, anticoagulants, and statins; systolic BP (SBP) and diastolic BP (DBP) on initial evaluation; acute emergency department or in-hospital antihypertensive treatment; and change in mean arterial BP (d MAP 5 MAP at admission 2 the lowest MAP before MRI scan). We determined the most likely etiology for the qualifying ICH based on available clinical data and investigations and used Boston criteria for diagnosing CAA-related ICH. 15 Standard protocol approvals, registrations, and patient consents. This study was approved by the Committee on Clinical Investigations at Beth Israel Deaconess Medical Center.
MRI time, acquisition, and analysis. All patients underwent MRI according to a standardized protocol as part of routine clinical assessments. The protocol included T1-and T2-weighted, fluid-attenuated inversion recovery (FLAIR), gradient-echo T2*-weighted (GRE), axial trace DWI with 2 b-values (0 and 1,000), and apparent diffusion coefficient (ADC) sequences. All studies were performed on 1.5T scanners. Sequences typically included 24-30 slices of 5-mm thickness with a matrix size of 128 3 128. The imaging parameters were as follows: T1 (repetition time [TR] 420 ms; echo time [TE] 8.8 ms); T2 (TR 4,500 ms; TE 95 ms); FLAIR (TR 9,000 ms; TE 84 ms); GRE (TR 835 ms; TE 26 ms); diffusion tensor imaging (TR 4,528 ms; TE 103 ms).
Approximately 77% of the patients had their MRI within 3 days of ICH onset; 13% within 4-7 days; and 10% between 7 and 31 days. Only 1% of patients had their MRI after 30 days.
Assessment of EPVS. EPVS were rated on axial T2-weighted MRI using a validated visual rating scale. 16, 17 EPVS were defined as #2 mm round or linear CSF isointense lesions (T2hyperintense and T1/FLAIR hypointense with respect to brain) along the course of penetrating arteries (figure). They were distinguished from lacunes by the latter's large size (.2 and #15 mm) and surrounding rim of FLAIR hyperintensity. 11, 18, 19 Lacunar infarcts were defined as round or ovoid FLAIR lesions measuring 3-15 mm in diameter in the white matter and BG. 19 EPVS were separated and rated in the BG and CSO regions using the following rating categories: 0 5 no EPVS, 1 5 1 to #10 EPVS, 2 5 11 to 20 EPVS, 3 5 21 to 40 EPVS, and 4 $40 EPVS. EPVS were counted in both sides, ipsilateral and contralateral to the ICH, on the brain slice showing the greatest extent of EPVS. However, only the contralateral side was rated whenever the structural damage caused by ICH was severe enough to limit accurate rating of EPVS in its immediate vicinity. A sum score of EPVS was calculated as the sum of EPVS in BG and CSO regions. For the purpose of this analysis, EPVS were categorized into 0-2 vs 3-4 grades. We defined high BG-EPVS or CSO-EPVS (grades 3-4) as .20, in line with the most severe category of EPVS used in previous studies. 20, 21 Assessment of DWI lesions. Small DWI lesions were defined as hyperintense lesions on DWI sequence, measuring less than 1 cm in diameter, with corresponding dark areas on ADC maps. Small DWI lesions in close proximity (,20 mm) to an ICH were excluded. The locations of SA-DWIL were classified as cortical or cortical-subcortical, deep (including brainstem), and cerebellum. 6 ICH location was categorized as lobar or deep (BG and thalamus).
Assessment of hematoma volume. Hematoma volume on baseline CT scan was measured by Medical Image Processing, Analysis, and Visualization (MIPAV) software (CIT, NIH, Bethesda, MD). 22 Regions of interest (ROIs) were manually drawn by tracing the perimeters of the hematoma in each slice, throughout the hemorrhagic lesion. The traced ROIs in every slice were then summed after adjusting for slice thickness to yield a hematoma volume. The volume of ICH was calculated as the sum of the ICH area on each CT slice 3 (slice thickness 1 interslice gap). 5 Assessments of hematoma volumes were carried out collectively after completion of MRI-based assessments and locking of recorded data to avoid the confounding effects of potential unblinding.
Assessment of WMH. The presence and extent of WMH were assessed by using the Fazekas scale 23,24 for periventricular white matter (PVWM) and deep white matter (DWM). Fazekas scale is a 4-point scale, with scores ranging from 0 to 3 on sagittal T1-hypointense, coronal FLAIR, and axial T2 hyperintense lesions. A sum score of WMH was calculated as the sum of the PVWM and DWM scores.
Assessment of microbleeds. Microbleeds were defined as small areas (2-10 mm in diameter) of signal void with associated blooming seen on GRE image. Microbleeds were counted and classified as lobar (including cerebellum) and deep (including brainstem) by using the Microbleed Anatomical Rating Scale. 19, 25 Two trained raters (B.W. and X.Y.) independently reviewed MRIs from 10 randomly selected scans. The inter-rater Cohenweighted kappa was 0.97 for ICH volume, 0.78 for number of SA-DWIL, 0.8 for the class of EPVS (0-4), 0.77 for WMH score, and 0.8 for number of microbleeds. The corresponding intrarater reliability Cohen-weighted kappa was 0.85 or above. Therefore, only one operator (B.W.) assessed the remaining scans, with occasional support from X.Y. Discussion or a third party were used to reach consensus regarding disagreements.
Statistical analysis. We divided the patients into 2 groups based on the presence vs absence of SA-DWIL. We compared the clinical and imaging characteristics, including EPVS, of patients with and without SA-DWIL using x 2 test and Fisher exact test for categorical variables, and 2-sample t test or Mann-Whitney U test for continuous variables, as appropriate. We used univariate binary logistic regression to determine the variables associated with SA-DWIL. Variables with p , 0.1 on univariate analysis were entered into multivariate logistic modeling. A p value #0.05 was considered to be statistically significant. All statistical analyses were carried out using SPSS (version 16; IBM, Armonk, NY).
RESULTS A total of 573 ICH patients were admitted to our stroke service from October 2007 to August 2014. Sixty-nine patients had secondary causes, and 9 had isolated IVH. Therefore, 495 patients with a diagnosis of primary ICH were screened for inclusion eligibility. A total of 294 patients were excluded for the following reasons: no MRI scan (n 5 259), poor quality of MRI images (n 5 11), imaging data not available (n 5 4), and infratentorial hemorrhage (n 5 20). Therefore, the final cohort included in this analysis consisted of 201 patients. Table 1 summarizes the characteristics of included and excluded patients with primary ICH. Tables 2 and 3 summarize the clinical and radiologic characteristics of all included patients, and the subgroups with SA-DWIL and without SA-DWIL.
Prevalence and distribution of EPVS. EPVS were detected on MRI in 99% of patients. The categories of CS-EPVS were as follows: category 0 (n 5 0 vs 2), 1 (n 5 2 vs 23), 2 (n 5 6 vs 61), 3 (n 5 42 vs 51), and 4 (n 5 6 vs 8) in patients with SA-DWIL (n 5 56) vs those without SA-DWIL (n 5 145). The corresponding categories of BG-EPVS in patients with SA-DWIL compared with those without SA-DWIL were n 5 0 vs 1, 17 vs 72, 21 vs 50, 13 vs 15, and 5 vs 7, respectively. Overall, EPVS were rated as high CSO-EPVS in 53.2% and high BG-EPVS in 19.9% of patients; 13.4% had both high CSO-EPVS and high BG-EPVS.
Prevalence and distribution of SA-DWIL. Small DWI lesions were detected in 27.9% of patients. The DWI lesions were located in the cortex in 46.4% of patients; subcortical structures in 37.5%; deep structures in 14.3%; and cerebellum in 1.8%. The overall distribution of DWI lesions' locations did not significantly differ between patients with probable CAArelated ICH vs those with hypertensive ICH; most SA-DWIL were cortical in both groups.
The DWI lesions were more commonly seen in patients with probable CAA-related ICH (32.9%) than in patients with hypertensive ICH (32.8% vs 25.2%; p 5 0.07). The prevalence of SA-DWIL was approximately 45% in patients with high CSO-EPVS and those with high BG-EPVS, and 63.0% in patients with As tables 2 and 3 illustrate, the prevalence of intraventricular and subarachnoid extension of ICH, high CSO-EPVS, and high BG-EPVS was more common in patients with SA-DWIL. The prevalence of microbleeds and their total number were also greater in patients with SA-DWIL, and the anatomical distribution of microbleeds differed between patients with vs without SA-DWIL (p 5 0.004), where lobar and mixed locations were more common in the former group. In addition, the overall WMH score, initial ICH volume, and mean delta MAP were greater in patients with SA-DWIL compared to those without SA-DWIL, and the time from ICH onset to MRI scan was longer in the SA-DWIL group. These variables were entered into subsequent multivariate logistic regression models. Table 4 lists the results of the multivariate logistic regression analyses. Larger ICH volume and high CSO-EPVS were independently associated with the presence of SA-DWIL. There was a trend for an association between high BG-EPVS and the presence of SA-DWIL (p 5 0.066).
In additional exploratory analyses, we found no interaction between ICH subtype (hypertensive vs CAA) and the potential association between CSO-EPS and SA-DWIL in univariate (p 5 0.079) or Abbreviations: BG 5 basal ganglia; CAA 5 cerebral amyloid angiopathy; CSO 5 centrum semiovale; DWI 5 diffusion-weighted imaging; EPVS 5 enlarged perivascular spaces; ICH 5 intracerebral hemorrhage; MB 5 microbleed; SA-DWIL 5 small acute lesions on diffusion-weighted imaging; WMD 5 white matter disease. multivariate analyses (p 5 0.389). We also found that high CSO-EPVS was independently associated with SA-DWIL in patients with CAA-ICH (p 5 0.027) and non-CAA ICH (p , 0.001), when adjusting for the presumed etiology of ICH. We found a significant association between the number of microbleeds and white matter disease severity score (p 5 0.001).
In contrast, the association between the number of microbleeds and EPVS category was not significant (p 5 0.765 for CS-EPVS and 0.271 for BG-EPVS).
DISCUSSION
In this cross-sectional, single-center study, we found that high CSO-EPVS were significantly more prevalent in ICH patients with SA-DWIL compared to their counterparts without SA-DWIL, and patients with high CSO-EPVS had greater number of SA-DWIL. We also found a similar trend between high BG-EPVS and the presence of SA-DWIL. In addition, larger ICH volume was associated with the presence and the number of SA-DWIL. Similar to previous studies, SA-DWIL were noted in more than a quarter of our ICH patients, 4, 5, 9 and were predominantly located in the cortical and subcortical regions. The lack of a statistically significant association between high BG-EPVS and SA-DWIL is likely an artifact of our sample size. Our results might have also been confounded by the fact that a larger proportion of patients with high BG-EPVS also had high numbers of CSO-EPVS, and not vice versa.
The pathophysiology of SA-DWIL in patients with ICH is not entirely clear. Previous studies have linked SA-DWIL to underlying small vessel arteriopathy. 2, [4] [5] [6] Small DWI lesions seem to be more common in ICH related to possible CAA and are associated with small-vessel pathogenesis, such as WMH and cerebral microbleeds. EPVS are also associated with other features of small vessel disease such as WMH and lacunes. 16 They are part of the spectrum of small vessel disease and are emerging as a neuroimaging marker of small vessel disease. Our finding of an association between the presence of high EPVS, in particular CSO-EPVS, and SA-DWIL is novel. It adds to the body of literature implicating small vessel arteriopathy in the pathogenesis of SA-DWIL following ICH. It raises the intriguing hypothesis that EPVS might serve as conduits to facilitate the transport of toxic blood products to brain areas distant from the hemorrhage resulting in SA-DWIL visible on MRI. Previous reports support the notion that blood can extend into the perivascular spaces following subarachnoid and intracerebral hemorrhages. 13, 14, 26, 27 Our finding that larger ICH volume is associated with SA-DWIL is in agreement with previous reports. 4 A combination of local compression of the hematoma, cytotoxic injury, and inflammation ensues after ICH. We hypothesize that larger hematomas might result in the release of more hemoglobin degradation products and inflammatory cytokines that extend via EPVS and subarachnoid space to contribute to the pathogenesis of SA-DWIL in distant regions. This hypothesis may merit future investigations.
There are conflicting reports regarding the relationship between BP lowering and SA-DWIL in ICH. Some studies reported significant association between BP reduction and the presence of SA-DWIL in most patients with hypertensive ICH, 1, 4, 8, 9 whereas others did not. 5 We observed a nonsignificant trend between d MAP and SA-DWIL. This discrepancy may be partly due to the difference in patient population. The prevalence of hypertensive ICH in our cohort was 55.2% compared to 62%-91.5% in other studies. 1, 4, 8, 9 Interestingly, we found that the total number of small DWI lesions in patients with high BG-EPVS was lower than in that in patients without high BG-EPVS. This finding might seem counterintuitive, but is likely attributed to lower prevalence of hypertensive ICH in our cohort.
Our study has limitations largely attributed to its retrospective nature. There is a possibility of a selection bias towards patients with mild to moderately sized hemorrhages, as patients with more severe hemorrhages might have been too unstable to get an MRI scan. To minimize this possibility, we extended the time from ICH onset to MRI to 4 weeks. This is in line with previous studies. Furthermore, the median time to MRI was 2 days in our study. We were also unable to blind the EPVS rater to the DWI lesions. Therefore, a measurement bias towards the study hypothesis cannot be excluded. In addition, it is Abbreviations: BG 5 basal ganglia; CI 5 confidence interval; CSO 5 centrum semiovale; EPVS 5 enlarged perivascular spaces; ICH 5 intracerebral hemorrhage; MAP 5 mean arterial blood pressure; MB 5 microbleed; SA-DWIL 5 small acute lesions on diffusion-weighted imaging; WMD 5 white matter disease.
important to point out that our observed association of EPVS with SA-DWIL does not necessarily imply causation. Therefore, our findings should be considered hypothesis-generating. Furthermore, we cannot exclude the possibility that the observed association between EPVS and DWI lesions in our study is merely a reflection of EPVS being a marker of an active occlusive arteriopathy contributing to both hemorrhagic and ischemic cerebrovascular disease manifestations. We only collected data on EPVS based on dichotomized categories of 0-2 vs 3-4, and not the absolute number of EPVS within each individual category. This may have limited our ability to examine the dose effect of EPVS on the risk of small DWI lesions. Finally, long-term functional outcome data were not available to allow us to assess the prognostic value of EPVS. Future prospective studies examining the relationship between EPVS and functional outcome in ICH patients are warranted.
Our data suggest that high EPVS, in particular CSO-EPVS, and larger hematoma volume are independent predictors for SA-DWIL after ICH. Our findings could provide a new explanation for the pathophysiologic mechanisms predisposing to SA-DWIL after ICH. Future prospective longitudinal studies are required to confirm our findings.
